Description: Ibere Pharmaceuticals focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Home Page: www.iberepharma.com
IBER Technical Analysis
2005 Market Street
Philadelphia,
PA
19103
United States
Phone:
267 765 3222
Officers
| Name | Title |
|---|---|
| Mr. Osagie O. Imasogie Esq. | Chairman & CEO |
| Ms. Lisa M. Gray CPA, CPA, CVA | CFO, Exec. VP & Director |
| Mr. Zoltan Kerekes J.D. | COO, Exec. VP & Director |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 17.1525 |
| Price-to-Book MRQ: | 1.3034 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-04-20 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |